Navigation Links
Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007
Date:3/6/2008

40,714 52,637 69,532 448,397

Stock based

compensation 539,156 403,550 64,104 4,704,805

Other non-cash

items - - 224,508 1,383,537

Net change in

non-cash working

capital 530,300 811,922 584,766 2,435,221

-------------------------------------------------------------------------

Cash used in

operating

activities (13,569,594) (12,155,372) (11,052,462) (66,551,036)

-------------------------------------------------------------------------

INVESTING ACTIVITIES

Intellectual

property (852,498) (842,610) (1,033,035) (6,351,778)

Capital assets (92,221) (35,837) (61,309) (715,569)

Purchase of

short-term

investments (949,496) (1,035,427) (22,195,253) (49,068,963)

Redemption of

short-term

investments 6,573,000 13,808,000 6,656,746 30,151,746

Investment in

BCY LifeSciences

Inc. - - 7,965 464,602

Investment in

Transition

Therapeutics

Inc. - - - 2,532,343

-------------------------------------------------------------------------

Cash provided by

(used in)

investing

activities 4,678,785 11,894,126 (16,624,886) (22,987,619)

-------------------------------------------------------------------------

FINANCING ACTIVITIES

Proceeds from

exercise of

stock options

and warrants 51,000 241,400 3,384,787 15,259,468

Proceeds from

private

placements - - 15,395,402 38,137,385

Proceeds from

public

offerings 12,063,394
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Media Advisory - Oncolytics Biotech Inc. to Present at Bio CEO & Investor Conference
2. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
3. Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial
4. Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent
5. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment
6. Oncolytics Biotech Inc. Announces Filing of Phase 1/2 Clinical Trial with REOLYSIN(R)
7. Oncolytics Biotech Inc. Completes Patient Enrolment in U.K. Phase Ia/Ib Combination REOLYSIN(R)/Radiation Clinical Trial
8. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
9. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
10. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
11. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 Quorum Review IRB, the industry ... large clinical trials called Quick Step™ . The offering ... address the research industry’s need for seamless study start-up with ... available for studies planning 50 or more North American investigator ... North American site count of 80 or more. Qualifying studies ...
(Date:7/22/2014)... Biofeedback – When a behavioral problem ... medication to best treat it can become a matter ... electroencephalography (EEG) can help predict which medicine will offer ... adverse drug events. , The article “Medication Prediction ... issue of the journal Biofeedback offers evidence that quantitative ...
(Date:7/21/2014)... IL (PRWEB) July 21, 2014 ... and simple programming, the new Cole-Parmer® Digital ... is easy to operate for automated process ... for hands-free dispensing. The batch count function counts ... volume or totalizer tracks amount dispensed across multiple ...
(Date:7/21/2014)... , July 21, 2014  Mike Patterson, CEO ... $1.6 million in Series Seed B funding to ... sensors for the life science, defense, intelligence, and ... Partners led the round and was joined by ... Said Patterson , "This round of funding ...
Breaking Biology Technology:Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 2Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 3Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 3New Easy-View Cole-Parmer Digital Gear Pump Drive Makes Performance Monitoring Effortless 2Global Graphene Manufacturing Leader, Graphene Frontiers, Receives Series Seed B Funding To Assure Production Of The Next Generation Of Biological And Chemical Sensor Technology 2
... (Nasdaq: WHRT, TSX:,WHT) Since January 2008, ... various financing alternatives to raise additional,capital, including ... order to continue operations. At April 30, ... of approximately $0.5 million and,current liabilities of ...
... Barr Pharmaceuticals,Inc. (NYSE: BRL ) today ... final approval from the U.S. Food and Drug,Administration ... to,manufacture and market a generic version of Yasmin(R) ... and marketed,by Bayer Schering Pharma, AG., On ...
... KENILWORTH, N.J., May 9 Schering-Plough,Corporation (NYSE: SGP ... 16, 2008, in Memphis, Tenn. At 8 a.m. (CDT) ... the meeting will be available to all interested,parties via ... the Annual Meeting, Fred Hassan, Chairman and CEO, will ...
Cached Biology Technology:WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders' Meeting 2WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders' Meeting 3WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders' Meeting 4Barr Announces Approval of Generic Yasmin(R) 2Barr Announces Approval of Generic Yasmin(R) 3
(Date:7/22/2014)... challenges faced by researchers in modifying properties of nanomaterials ... simple technique, thanks to recent innovative studies conducted by ... Through the use of a simple, efficient and low ... research teams, led by Professor Sow Chorng Haur from ... Science, demonstrated that the properties of two different types ...
(Date:7/22/2014)... cost-effectiveness analysis of commercial diet programs and pills, the ... best value for the money. The Jenny Craig regimen ... most expensive option tested, according to researchers at Duke-National ... findings, published in the June issue of the journal ... and weight-loss benefits per dollar spent as insurance carriers ...
(Date:7/22/2014)... NY -- As part of a multinational, collaborative effort, ... Sinai have helped identify over 100 locations in the ... in the largest genomic study published on any psychiatric ... published online in Nature , point to biological ... lead to new approaches to treating the disorder, which ...
Breaking Biology News(10 mins):NUS scientists use low cost technique to improve properties and functions of nanomaterials 2NUS scientists use low cost technique to improve properties and functions of nanomaterials 3Study compares cost-effectiveness of weight-loss programs and drugs 2Study compares cost-effectiveness of weight-loss programs and drugs 3Mount Sinai scientists and international team shed new light on schizophrenia 2Mount Sinai scientists and international team shed new light on schizophrenia 3
... New combinations of agents based on the oldest synthetic ... spread of malaria parasites and make a significant contribution ... "Roll Back Malaria Initiative." In a study on 160 ... medicine from the Heidelberg University Hospital have shown that ...
... Wash. -- Some researchers hope to turn plants into ... this, scientists have to learn how to convert plant ... cheaply and efficiently. In new research, chemists have successfully ... directly into the building block called HMF in one ...
... Individuals with heart disease are twice as likely to ... the medical community has largely been unable to explain. ... Hospital, in conjunction with The Montral Heart Institute, University ... genetic variations that contribute to depression in heart disease ...
Cached Biology News:Old stain in a new combination 2Old stain in a new combination 3Plastic that grows on trees, part two 2Genetic factors may predict depression in heart disease patients 2Genetic factors may predict depression in heart disease patients 3
... T Squareds patented high efficiency dynamic valve ... With the most compact, lightweight package in ... use in portable air and gas applications., ... high efficiency. , Includes DC Motor. ...
...
Alkaline Phosphatase (E. coli C75), 100 units. Removes 5'-phosphates from DNA. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Alkaline Phosphatases....
... CyScribe First-Strand cDNA Labeling System - ... 50 reactions. For the generation and ... reagents are packaged together for complete ... protocols can be used for performing ...
Biology Products: